Chen Chi-Ling, Kuo Ming-Jeng, Yen Amy Ming-Fang, Yang Wei-Shiung, Kao Jia-Horng, Chen Pei-Jer, Chen Hsiu-Hsi
Graduate Institute of Clinical Medicine, College of Medicine, National Taiwan University, Taipei, Taiwan.
Graduate Institute of Epidemiology and Preventive Medicine, College of Public Health, National Taiwan University, Taipei, Taiwan.
JNCI Cancer Spectr. 2020 May 8;4(5):pkaa036. doi: 10.1093/jncics/pkaa036. eCollection 2020 Oct.
A gender difference in hepatocellular carcinoma (HCC) that men have higher incidence than women has long been noted and can be explained by the cross-talk between sex hormones and hepatitis B virus/hepatitis C virus (HBV/HCV). Whether metabolic factors yield similar sexual difference in non-HBV/HCV-HCC remains elusive.
There were 74 782 hepatitis B surface antigen (HBsAg)/antibody to hepatitis C virus (anti-HCV) negative residents who participated in the Keelung Community-Based Integrated Screening program and were followed in 2000-2007. Incident HCC was identified by linkage to the Taiwan Cancer Registry. Cox proportional hazards regression models were used to estimate the association between metabolic factors and HCC stratified by sex. All statistical tests were 2-sided.
With 320 829 follow-up person-years, 99 residents developed HCC. The adjusted hazard ratios (aHR) were 2.10 (95% confidence interval [CI] = 1.07 to 4.13) and 3.71 (95% CI = 2.01 to 6.86) for prediabetes and diabetes, respectively, in men. The corresponding adjusted hazard ratios were 1.16 (95% CI = 0.48 to 2.83) and 1.47 (95% CI = 0.65 to 3.34) in women. Compared with normal weight (body mass index [BMI] = 23-25), underweight (BMI < 21, HR = 3.56, 95% CI = 1.18 to 10.8) and overweight (BMI = 25 to <27.3, HR = 3.81, 95% CI = 1.43 to 10.2) were associated with an elevated risk in men. The statistically significant gradient relationship per advanced BMI category was noted in women (aHR = 1.41, 95% CI = 1.07 to 1.87). The HCC-fasting glucose ( = .046) and HCC-BMI ( = .03) associations were statistically significantly modified by sex. Elevated aspartate aminotransferase, aspartate aminotransferase-to-platelet index and fibrosis index, and habitual alcohol consumption were related to HCC only in men, whereas increased alanine aminotransferase and lower platelet levels predicted HCC risk in women.
We found that BMI-HCC associations were U-shape for men and linear for women, and the elevated HCC risk began from glucose impairment in men only. Whether good glycemic and weight control can reduce HCC risk warrants further investigation.
长期以来人们注意到肝细胞癌(HCC)存在性别差异,男性发病率高于女性,这可以通过性激素与乙型肝炎病毒/丙型肝炎病毒(HBV/HCV)之间的相互作用来解释。代谢因素在非HBV/HCV-HCC中是否产生类似的性别差异仍不清楚。
有74782名乙型肝炎表面抗原(HBsAg)/丙型肝炎病毒抗体(抗-HCV)阴性居民参与了基隆社区综合筛查项目,并在2000年至2007年期间接受随访。通过与台湾癌症登记处的数据链接确定新发HCC病例。采用Cox比例风险回归模型估计按性别分层的代谢因素与HCC之间的关联。所有统计检验均为双侧检验。
在320829人年的随访中,有99名居民发生了HCC。男性中,糖尿病前期和糖尿病的调整后风险比(aHR)分别为2.10(95%置信区间[CI]=1.07至4.13)和3.71(95%CI=2.01至6.86)。女性相应的调整后风险比分别为1.16(95%CI=0.48至2.83)和1.47(95%CI=0.65至3.34)。与正常体重(体重指数[BMI]=23-25)相比,体重过轻(BMI<21,HR=3.56,95%CI=1.18至10.8)和超重(BMI=25至<27.3,HR=3.81,95%CI=1.43至10.2)与男性HCC风险升高相关。在女性中,观察到每个BMI升高类别存在统计学显著的梯度关系(aHR=1.41,95%CI=1.07至1.87)。HCC与空腹血糖(P=0.046)和HCC与BMI(P=0.03)的关联在性别上有统计学显著的修饰作用。天冬氨酸转氨酶、天冬氨酸转氨酶与血小板指数以及纤维化指数升高和习惯性饮酒仅与男性HCC相关,而丙氨酸转氨酶升高和血小板水平降低则预测女性的HCC风险。
我们发现BMI与HCC的关联在男性中呈U形,在女性中呈线性,且仅在男性中HCC风险升高始于血糖受损。良好的血糖和体重控制是否能降低HCC风险值得进一步研究。